Stoke Therapeutics Inc (NASDAQ:STOK)

4.76
Delayed Data
As of Dec 08
 +0.17 / +3.70%
Today’s Change
3.35
Today|||52-Week Range
14.00
-48.43%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 18.00, with a high estimate of 35.00 and a low estimate of 6.00. The median estimate represents a +278.15% increase from the last price of 4.76.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.66
Sales
$3.8M
Reporting Date
Mar 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.32%
 
 
 
 
 
 
Growthannually 4.57%
 
 
 
 
 
 

Sales

Growthquarterly 15.81%
 
 
 
 
 
 
Growthannually 15.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.